Thesis

Personalized nootropic supplements for cognitive enhancement

New York City, New York, United States

About Thesis

Thesis specializes in creating personalized nootropic supplements aimed at enhancing cognitive functions like memory, creativity, and motivation. Their products work by offering custom blends tailored to individual goals and lifestyles, which users can discover through an online quiz. After taking the quiz, customers receive a starter kit with four different nootropic blends to sample over a month, allowing them to find the blend that best suits their needs. Additionally, users have the option to consult with wellness coaches and nootropic experts to further refine their choices. Thesis stands out from competitors by focusing on high-quality, rigorously tested ingredients sourced from the USA, including functional mushrooms and choline sources. The company's goal is to help health-conscious individuals, such as students, professionals, and athletes, optimize their brain performance through effective and safe cognitive enhancement.

New York City, New YorkHeadquarters
2017Year Founded
$13.3MTotal Funding
SERIES_ACompany Stage
Healthcare, Consumer GoodsIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Flexible Work Hours
Unlimited Paid Time Off
Hybrid Work Options
Wellness Program
Company Equity
Professional Development Budget

Risks

Increased competition from established brands could dilute Thesis's market share.
Potential regulatory scrutiny may lead to higher operational costs for Thesis.
Supply chain disruptions could affect the availability of key ingredients for Thesis.

Differentiation

Thesis offers personalized nootropic supplements tailored to individual brain chemistry.
The company uses high-quality, USA-sourced ingredients like functional mushrooms and choline.
Thesis provides wellness coaching to optimize cognitive enhancement for each customer.

Upsides

Growing interest in personalized health solutions boosts demand for Thesis's products.
The global nootropics market is projected to grow at a 12.5% CAGR until 2030.
Subscription-based models in health and wellness are seeing increased consumer adoption.

Funding

Total raised$13.26 M
Latest valuation$42.00 M
StageSERIES_A